Uterine cervix carcinoma in situ
MONDO:0042487Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003
Also known as: CIN 3 aJCC v6, CIN grade 3 aJCC v6, FIGO stage 0 carcinoma of cervix, FIGO stage 0 carcinoma of cervix uteri, FIGO stage 0 carcinoma of the cervix, FIGO stage 0 carcinoma of the cervix uteri, FIGO stage 0 carcinoma of the uterine cervix, FIGO stage 0 carcinoma of uterine cervix
2869 clinical trials for this condition and its sub-types, 15 tagged with Uterine cervix carcinoma in situ itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Turmeric trial for cervical precancer pulled before it began
Disease control CancelledThis early-phase trial aimed to test whether curcumin (the active compound in turmeric) could safely help treat cervical precancer (CIN3). It planned to give 500 mg of curcumin twice daily for 12 weeks to women with CIN3. However, the study was withdrawn before enrolling any part…
Early phase 1 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a simple HPV test replace colposcopy for cervical cancer Follow-Up?
Diagnosis OngoingThis study compares two ways to check for returning cervical pre-cancer after treatment: the standard colposcopy exam versus a high-risk HPV DNA test. Over 2,200 women who were treated for high-grade cervical lesions will be randomly assigned to one of the two follow-up methods. …
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Cervical cancer screening showdown: pap vs. blood test study pulled
Diagnosis CancelledThis study was designed to compare the standard Pap smear with a new blood test that looks for three proteins linked to cervical cell changes. It planned to include adults aged 18-85 in good health. However, the study was withdrawn before enrolling any participants, so no results…
Sponsor: Timser SAPI de CV • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC